Intraperitoneal flucytosine in the management of fungal peritonitis in patients on continuous ambulatory peritoneal dialysis

Am J Kidney Dis. 1988 Jun;11(6):465-7. doi: 10.1016/s0272-6386(88)80080-5.

Abstract

Five episodes of fungal peritonitis were treated by intraperitoneal instillation of 5-flucytosine (5-Fc) while the patients remained on their usual schedule of dialysis. Therapeutic, nontoxic dialysate and serum concentrations of 5-Fc were achieved. Although some patients transiently responded with improved symptoms, a drop in their dialysate WBC count and negative cultures, all patients required removal of their dialysis catheters for cure. It is concluded that intraperitoneal (IP) 5-Fc, as used in this study, is not efficacious in the treatment of fungal peritonitis.

MeSH terms

  • Candidiasis / drug therapy*
  • Candidiasis / etiology
  • Flucytosine / administration & dosage*
  • Flucytosine / therapeutic use
  • Humans
  • Instillation, Drug
  • Peritoneal Cavity
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy*
  • Peritonitis / etiology

Substances

  • Flucytosine